Recent developments include CMS unveiling its BALANCE model, a voluntary Medicare and Medicaid coverage pathway that includes price negotiations and supplemental lifestyle support, with coverage beginning in 2026 for Medicaid and 2027 for Medicare Part D [2]
Qsymia can cause nausea, but it is less common and typically less severe than with GLP-1 medications
NICE and MHRA guidance recommend telling your clinician if you take blood thinners, as pressing slightly longer or choosing the abdomen can reduce bruising risk
The MHRA has issued drug safety updates relevant to renal safety
For early to moderate type 2 diabetes, GLP-1 medications are increasingly preferred due to weight loss benefits, lower hypoglycemia risk, and cardiovascular protection
In mtDNA replication, first strand synthesis begins with formation of the D-loop